Funding Opportunity: Alzheimer’s Drug Discovery Foundation Program to Accelerate Clinical Trials (PACT)
“The PACT RFP supports IND-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias. Both disease-modifying and symptomatic agents will be considered.
This funding opportunity prioritizes diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP.
Average Award
Up to $3,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment.”
Opportunity Deadline:
This opportunity has multiple funding cycles through 2021.
LOI deadlines include February 5, May 28, and October 1.
If you have questions about this application, please contact Joseph Loftus at Foundation Relations (joloftus@bu.edu) or click here to learn more.